Providing due diligence support for a clinical stage, type 1 diabetes immunotherapy project

Challenge A clinical stage, type 1 diabetes immunotherapy project needed convincing partnering materials and advice on data room structure and due diligence preparations.
Learn More

Providing due diligence on a pain in-licensing opportunity

Challenge A European pharma company needed to conduct an expert reality check on a pain in-licensing opportunity.
Learn More

Providing due diligence of a novel drug formulation

Challenge An established medical device company looking to make a strategic investment needed commercial, regulatory, IP and technical due diligence on an investment opportunity in the diabetes...
Learn More

Providing due diligence on a cell biology reagents investment

Challenge A major UK bioscience investor needed due diligence on a cell biology reagents investment opportunity.
Learn More

Assessing oral delivery of biopharmaceuticals

Challenge An incoming lead investor needed to assess a proprietary platform technology for the oral delivery of biological drugs.
Learn More

Providing clinical due diligence of a novel biologic to treat respiratory disease

Challenge A pharma company looking to purchase an asset needed a respiratory consultant to conduct clinical due diligence of a Phase II biologic designed to treat a respiratory condition.
Learn More

Providing Phase lll-ready radiolabeled antibody due diligence

Challenge A well-capitalized strategic investor looking to enter the radiopharmaceuticals market wanted to conduct clinical due diligence on a novel radioisotope-conjugated antibody designed to treat...
Learn More

Providing technical due diligence on a Rubidium-82 radionuclide generator

Challenge Our client was looking to build a capability in radionucleotide imaging and was seeking merger and acquisition opportunities in Europe and the US. One target company was developing a new...
Learn More

Radionucleotide imaging due diligence

Challenge A well-capitalized Swiss pharma company needed a clinical and commercial reality check for a new imaging technology being developed that was under consideration for acquisition.
Learn More

Providing scientific and immunological mechanism of action due diligence for a big pharma client

Challenge A major pharma company needed scientific and immunology due diligence support on a novel cyclic peptide, targeting the complement cascade system.
Learn More

Providing pharmacovigilance due diligence of a Phase lll oncology program

Challenge A major pharmaceutical company asked us for support in the medical safety and pharmacovigilance due diligence and assessment of a Phase III in-licensing opportunity. The drug in question...
Learn More

Providing due diligence in neurology

Challenge A venture capital investor needed an assessment of the technical, regulatory and market risks in a neuroscience specialty pharma company developing a range of products through the 505...
Learn More